Buy Stock Research

Following are our Pfizer Stock Research Notes. We will continue to update this page. If you want to buy Pfizer stock, ask us about the best price to buy, and our price targets for the stock.

Pfizer is the world’s largest pharmaceutical firm, with annual sales nearly $50 billion. After the sale of its consumer health-care division to J&J, prescription drugs now account for more than 90% of sales. Pfizer is the engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Pfizer’s global R&D is working on every possible disease.  Its Pharmaceutical segment offers the following medicines:

• Lipitor for elevated cholesterol levels in the blood;
• Norvasc for hypertension;
• Caduet for cardiovascular events;
• Chantix/Champix for smoking cessation;
• Lyrica for neuropathic pain;
• Geodon/Zeldox, a psychotropic agent;
• Aricept for Alzheimers disease.
• Celebrex for arthritis pain, and inflammation and acute pain;
• Vfend for esophageal candidiasis and blood stream infections;
• Zyvox for bacterial infections;
• Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable;
• Viagra for erectile dysfunction;
• Detrol and Toviaz for overactive bladder;
• Camptosar for metastatic colorectal cancer;
• Sutent, an oral multi-kinase inhibitor;
• Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and
• Genotropin for growth disorders.

PFIZER FINANCIAL HIGHLIGHTS

Fiscal Year Ends: 31-Dec
Most Recent Quarter (mrq): 31-Dec-08
Profitability

• Profit Margin (ttm): 16.78%
• Operating Margin (ttm): 34.77%
• Management Effectiveness
• Return on Assets (ttm): 9.27%
• Return on Equity (ttm): 13.10%

Income Statement

• Revenue (ttm): 48.30 Bn
• Revenue Per Share (ttm): 7.179
• Qtrly Revenue Growth (yoy): N/A
• Gross Profit (ttm): 40.18B
• EBITDA (ttm): 21.88B
• Net Income Avl to Common (ttm): 8.02B
• Diluted EPS (ttm): 1.20
• Qtrly Earnings Growth (yoy): N/A

Pfizer’s Viagra is a blockbuster (probably the biggest in the last 2 decades), but how long can it support Pfizer? Time is running out to come out with the next blockbuster. For that purpose, Pfizer decided to acquire Wyeth, which has a better drug discovery pipeline, and more diversification in revenues, that can provide stable revenues. But, it looks like Pfizer has overpaid for Wyeth. Agreed, that Wyeth is a great business, but Pfizer agreed to pay 68 billion in this recessionary environment. Pfizer has also acquired rights to 12 sterile injectable products in the US and Europe. Pfizer should pay a much higher price for their recklessness and racial disregard for others.

Pfizer did not say whether Wyeth CEO Bernard Poussot would have a role after the deal closes but it has said he would stay on through the transition. Poussot is in line to get $53 million in severance payments if the acquisition is completed, according to regulatory filing last month.

Pfizer also operates several other businesses, including the manufacture of gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals.

In June 2008, Pfizer completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals, Inc. Pfizer has programs that can help, no matter your age or income. You may even qualify for free Pfizer medicines.

Pfizer has still not directly contacted the valve recipients. In January 1991, a suit was filed against the company in the USA on behalf of 55,000 valve recipients. Pfizer’s contributions will include expertise in the design and execution of clinical studies and interaction with global regulators as well as in product manufacturing techniques.

The collaboration will examine how human embryonic stem (hES) cells differentiate into retinal pigment epithelium (RPE) with the goal of developing stem cell-based therapies primarily for wet and dry macular degeneration (AMD). Pfizer charges much lower prices for the same drug in Thailand, Indonesia, India and other countries in the region.

Pfizer claims it is the first pharmaceutical company to put in place a comprehensive program of this type focused on EPC authentication as a means of deterring counterfeiting. Pfizer reinforces its message with direct-to-consumer magazine ads, such as one featuring a virile looking man around 40 saying: “A lot of guys have occasional erection problems. I chose not to accept mine and asked about Viagra.”

Corporate Affairs and Governance
Pfizer now requires shareholder approval for its use or that the Board of Directors seek ratification of its use should they initiate a poison pill defence without approval. Other reforms the company implemented include requiring annual elections for all Directors, and for Directors that receive a majority of withheld.

Pfizer doesn’t have to grant the advisory vote the shareholders want. And even if it does, shareholders can’t actually set executive compensation — that power is reserved for corporate boards.